| Name | Cvs Pharmacy #10387 |
|---|---|
| Organization Name | Washington Cvs Pharmacy Llc |
| Location | 2100 N 45th St, Seattle, Washington 98103 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (206) 633-1536 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
Perinatal depression has soared during the pandemic. But many mental health professionals are overwhelmed and can't take on new clients.
The Barbara Ann Karmanos Cancer Institute announced today it received a $3 million grant from the Herrick Foundation. The initial gift of $1 million launches The Herrick Foundation Cancer Research Challenge, a special initiative to increase research funding at the Karmanos Cancer Institute over the next four years. The additional commitment of $2 million will be given in match funding.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, announced today that several of its defensin-mimetic antibiotic compounds have shown antimicrobial efficacy in an animal model against the bacteria that causes anthrax.
› Verified 1 days ago
| NPI Number | 1891173985 |
| Organization Name | WASHINGTON CVS PHARMACY LLC |
| Doing Business As | CVS PHARMACY # 10387 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 2100 N 45th St, Seattle, WA 98103 |
| Phone Number | 206-633-1536 |
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
Perinatal depression has soared during the pandemic. But many mental health professionals are overwhelmed and can't take on new clients.
The Barbara Ann Karmanos Cancer Institute announced today it received a $3 million grant from the Herrick Foundation. The initial gift of $1 million launches The Herrick Foundation Cancer Research Challenge, a special initiative to increase research funding at the Karmanos Cancer Institute over the next four years. The additional commitment of $2 million will be given in match funding.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, announced today that several of its defensin-mimetic antibiotic compounds have shown antimicrobial efficacy in an animal model against the bacteria that causes anthrax.
› Verified 1 days ago
News Archive
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
Perinatal depression has soared during the pandemic. But many mental health professionals are overwhelmed and can't take on new clients.
The Barbara Ann Karmanos Cancer Institute announced today it received a $3 million grant from the Herrick Foundation. The initial gift of $1 million launches The Herrick Foundation Cancer Research Challenge, a special initiative to increase research funding at the Karmanos Cancer Institute over the next four years. The additional commitment of $2 million will be given in match funding.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat patients with acute infectious diseases and cardiovascular disorders, announced today that several of its defensin-mimetic antibiotic compounds have shown antimicrobial efficacy in an animal model against the bacteria that causes anthrax.
› Verified 1 days ago
Aids Healthcare Foundation Type: Pharmacy Location: 1016 E Pike St, Seattle, Washington 98122 Phone: (206) 568-2486 | |
Aids Healthcare Foundation Type: Pharmacy Location: 901 Boren Ave, Seattle, Washington 98104 Phone: (206) 624-1391 | |
American Artificial Limb Type: Medicare Supplier Location: 650 S Orcas St, Seattle, Washington 98108 Phone: (206) 324-1222 | |
Bob Johnsons Pharmacy Type: Long Term Care Pharmacy Location: 1407 Nw 85th St, Seattle, Washington 98117 Phone: (206) 782-5822 | |
Center For Prosthetics Orthotics In Type: Prosthetic/Orthotic Supplier Location: 411 12th Ave, Seattle, Washington 98122 Phone: (206) 328-4276 |